Executive Director, Late-Stage Clinical Development, Rare Diseases | Lead Team of 6 MDs | Boston Area: RETAINED SEARCH

Cornerstone Search Group
Published
June 28, 2020
Location
Work Remote, United States
Category
Job Code
cmBH2754csg
Contact Email
cmiras@cornerstonesg.com

Description

Executive Director, Late-Stage Clinical Development, Rare Diseases | Lead Team of 6 MDs | Boston Area: RETAINED SEARCH

SUMMARY:

In this very important Clinical Development Leadership position, you will play a significant role to help bring multiple important Rare Disease therapies to patients. You will lead a team of MDs accountable for the global later-stage development of multiple novel therapies to treat important autoimmune and neurological diseases and disorders. You will be part of a Company that has successfully discovered and developed complex novel therapies to treat multiple Rare Diseases, and that has been recognized as a Top Industry Innovator and Top Global Rare Diseases (RD) Leader too. This is a critical clinical development, medical strategy and people leadership role and opportunity with a Company that has the best of all worlds to offer, i.e. the financial strength and stability of a larger pharma, the nimbleness of a small biotech, high visibility, the chance to make significant contributions and impacts, and all of this with an expanding mid-sized biopharma that offers an attractive opportunity for continued individual growth and advancement.

LOCATION, RELOCATION AND WORK REMOTELY FROM HOME: Company is in the Boston, MA area. Company offers relocation assistance. Company will consider highly-qualified candidates that live outside of the Boston area that cannot relocate, i.e. will need to work remotely from his/her home, and travel to Boston as needed (post COVID-19) for important team, program and leadership meetings.

ATTRACTIVE FEATURES INCLUDE, AND ARE NOT LIMITED TO, THE FOLLOWING:

  • Develop multiple later-stage novel and important therapies to treat major Rare Diseases
  • Lead, manage, develop, and mentor a team of 6+ MDs to develop multiple late-stage therapies
  • Medical Strategy: make significant medical strategy contributions to each program and the entire RD TA
  • Visibility: report directly to the Head of RD TA, and N-1 from Head of R&D
  • Impact: communicate directly with TA and Sr. Management regarding focus, strategies etc. for the RD TA
  • Very attractive Co: join a Top RD Leader with multiple in-house FDA approved novel therapies & strong pipeline
  • Enjoy the financial stability & strength of a pharma and the nimbleness of a biotech (swift decision making)
  • Pipeline: this Company has a very strong early and later-stage pipeline of novel in-house and acquired assets
  • Track record: this Company has successfully discovered, developed, and received multiple FDA approvals
  • Advancement/growth: this company is established and rapidly expanding too, which offers attractive opportunities for continued growth, development, and career advancement

QUALIFICATIONS:

  • MD is required, and a PhD is a big plus
  • Later-stage clinical development experience (Phase 3 registrational studies/trials experience)
  • Direct/matrixed multi-functional management experience
  • Strong communication and presentation skills
  • Ability to work effectively in a nimble, and less cumbersome organizational structure, i.e. high visibility, swift decision-making etc.

CONFIDENTIALITY: All communications with Cornerstone Search Group are treated as confidential information

CONTACT:

Cliff Miras | Managing Partner | MD/Physician Specialty Search Practice Area Leader

E: cmiras@cornerstonesg.com

P: 973.656.0220 x711

LinkedIn: linkedin.com/in/cliffmiras

CORNERSTONE SEARCH GROUP

Pharma/Biotech Executive Search Specialists | A Forbes “Top 250 Search Firm” for 2018 & 2017

www.cornerstonesg.com

RECENTLY COMPLETED SEARCH ASSIGNMENTS:

  • CEO | US Country Head, Specialty Pharma
  • CEO | Start-up sterile injectable pharma
  • CMO | NYC biotech, Cellular Therapy
  • CMO | Reports to CEO | Leads 100+ | Early/later-stage Biotech | Boston area
  • CSO | Reports to President | Leads 850+ | Hem/Onc/IO TAs | EU based
  • SVP, Global Medical Affairs, Oncology | Reports to President | Leads 50+ | NYC area
  • SVP, Translational Medicine & Early Development, Oncology | Boston Biotech
  • VP, Oncology Drug Development | Reports to CMO | Leads 20+ | Early/later-stage Biotech | Boston
  • VP & Head of Research & Development, Oncology | Reports to CMO | Early-stage Biotech | NYC
  • VP, US Medical Affairs, Oncology | Reports to Head of GMA, Oncology | Leads 45+ team | NYC area
  • VP, Head of Real-World Evidence | Top 5 Pharma
  • 3 RWE TA Heads for newly-created RWE department at mid-size pharma | Boston Biotech
  • VP, Head of Clinical Operations
  • ED, Early Development, IO | Reports to Head, IO Early R&D | Top 10 Onc/IO Co | Philadelphia area
  • ED, Clinical R&D, Onc | Reports to Head. Clinical R&D Onc | Preclinical Onc/IO Biotech | NYC area
  • ED, Head of Program Management | Boston Biotech
  • SD, Clinical Research, Oncology | Boston Area Biopharma Oncology Leader
  • SD, Clinical Development, Immuno-Oncology | Cambridge Area Global Oncology Leader

Keywords: Executive Director, Clinical Development, Drug Development, NDA, FDA, Regulatory, Filings, Submissions, Phase, Trial, Study, Protocol, IND, CDP, Medical Affairs, Health Economics, Real World Evidence, RWE, Patient Reported Outcomes, MS, Multiple Sclerosis, Parkinson’s, Alzheimer’s, ALS, Lou Gehrig’s Disease, Amyotrophic Lateral Sclerosis, immunology, neurology, neuroscience, neurodegenerative, neuromuscular, Physician, Medical Doctor, M.D., Physician-Scientist, VP, Vice President

Apply
Drop files here browse files ...
PDF and .doc resume uploads are preferred. docx files are not supported.
Captcha